The Rodin (Research Of Determinants of INhibitor Development among PUPs with haemophilia) study: the clinical conundrum from the perspective of haemophilia treaters
Author:
Affiliation:
1. Division of Hematology-Oncology; Georgetown University Medical Center; Washington; DC; USA
2. Departments of Clinical Epidemiology and Biostatistics and Medicine; McMaster University; Hamilton; ON; Canada
Publisher
Wiley
Subject
Genetics(clinical),Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.12149/fullpdf
Reference12 articles.
1. Factor VIII products and inhibitor development in severe hemophilia A;Gouw;N Engl J Med,2013
2. Baseline comparability in clinical trials;Enas;Drug Inform J,1990
3. Gouw SC van den Berg HM van der Bom JG the PedNet and Rodin Study Group Factor VIII prophylaxis and inhibitor development in previously untreated patients with severe hemophilia A: the Rodin study http://igitur-archive.library.uu.nl/dissertations/2011-1110-200501/gouw.pdf
4. Statistical problems in the reporting of clinical trials;Pocock;N Engl J Med,1987
5. Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia;Kreuz;Thromb Haemost,2005
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies;Haemophilia;2019-05
2. Risk factors for inhibitor development in severe hemophilia A;Thrombosis Research;2018-08
3. Identification of aggregates in therapeutic formulations of recombinant full-length factor VIII products by sedimentation velocity analytical ultracentrifugation;Journal of Thrombosis and Haemostasis;2018-01-11
4. Traitement des anomalies de la coagulation;Pharmacie Clinique et Thérapeutique;2018
5. Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A;Haematologica;2017-10-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3